# Concomitant Therapy of H. Pylori

> **NCT01922765** · PHASE4 · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 540 (estimated)

## Conditions studied

- Gastritis, Gastric Ulcer, and Duodenal Ulcer

## Interventions

- **DRUG:** amoxicillin, clarithromycin, metronidazole, rabeprazole

## Key facts

- **NCT ID:** NCT01922765
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2014-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01922765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01922765, "Concomitant Therapy of H. Pylori". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01922765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*